Rank: Guest 
|
Posted By Richie H
Hi all (again sorry),
I have concerns on the suitability of our risk assessments for our small on site clinics which also have a self sufficienct pharmacy. Prescriptions are written by our site GP so no problems with the acutal authority for issuing medical prescriptions and qualified medical nurse staff issue the drugs.
We appear to be ignoring the fact that the drugs are there on our RAs - other than the pharmacy must be locked / secure when not occupied by member of staff. Do you consider this sufficient or should I request they actually consider quantities / types of drugs stored (similar to COSHH)?
Cheers, Richie
|
|
|
|
|
|
Rank: Guest
|
Posted By Descarte
Are they dispensing medicines, ie. counting tablets out etc.. ? else how would they be exposed?
Also you will find most pills are coated so that any dusts produced are totally harmless, mostly inert dusts or lime or sugar
Dangers of needles, Manunual handling, violence or abuse, lone working, clinical waste, hazardous waste, these areother things I would be looking at.
|
|
|
|
|
|
Rank: Guest
|
Posted By Rachael Palmer
Have you had a look at the Royal Pharmaceutical Society of Great Britain's website http://www.rpsgb.org.uk/ ? You may find some useful info there.
|
|
|
|
|
|
Rank: Guest
|
Posted By J Knight
Richie,
Some meds are subject to COSHH; cytotoxic meds for example, and sorry to contradict Descarte, but powdered meds may well be subject to COSHH, as would any incidental dusts which could affect the dispenser, rather than the patient, which is also the principle behind cytotoxics being subject to COSHH,
John
|
|
|
|
|
|
Rank: Guest
|
Posted By Descarte
Yes reading over my post again it dosnt seem to clear what I meant, obviously if you are handling powered pharmaceutical products these would need assessing.
My point was that all encapsulated and and tabletted drugs are coated in a sugar or lime coating, therefore any dusts produced whilst handling tablets would likely be inert. Of course this can also be determied by swab and dust sampling.
|
|
|
|
|
|
Rank: Guest
|
Posted By Richie H
I would like to thank you all for you comments, a great help and will do more research and review the risk assessments.
Much appreciated, if anyone has further comments by all means place on forum as i constantly review these pages.
Cheers, Richie
|
|
|
|
|
|
Rank: Guest
|
Posted By Descarte
Worked for Pfizer for a fair while as a safety advisor, if you have any questions feel free to ask, I will try and answer if I can
|
|
|
|
|
|
Rank: Guest
|
Posted By Rakesh Maharaj
Hi Richie,
Agree with all those who have commented on exposure to mutagenic, cytotoxic and teratogenic dust. Exposure to these in a pharmacy setting is most common during drug reconstitution - which should, according to RPSGB guidelines follow GLP. i.e. in a well maintained ventilation cupboard. PS: don't forget added effects on female pharmacists of child bearing age.
Regards
R
|
|
|
|
|
|
You cannot post new topics in this forum.
You cannot reply to topics in this forum.
You cannot delete your posts in this forum.
You cannot edit your posts in this forum.
You cannot create polls in this forum.
You cannot vote in polls in this forum.